Related Experiment Video
Updated: Aug 5, 2026
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex
Agnieszka Wawrzczak-Bargieła1, Małgorzata Jelonek-Kozioł2, Weronika Kumorek2,3
1Department of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, 31-343, Kraków, Poland. agnieszka.bargiela@if-pan.edu.pl.
Rationale:
Psilocybin (PSI) microdosing, defined as a repeated administration of sub-perceptual doses, has gained increasing attention as a potential therapeutic strategy for affective and anxiety disorders. However, some molecular mechanisms, particularly regarding epigenetic regulation in the medial prefrontal cortex (mPFC), remain poorly understood.
Objectives:
Therefore, the present study aimed to determine whether PSI microdosing induces adaptive epigenetic modifications in the rat mPFC in the absence of behavioural dysfunction, with a particular focus on chromatin accessibility, transcriptional regulators, and plasticity-related genes.
Methods:
Rats were administered PSI or a vehicle every second day for 21 days. Behavioural impact was assessed using prepulse inhibition (PPI) of the acoustic startle response (ASR) and the novel object recognition test (NOR). Molecular dynamics in the mPFC were analysed via Western blot and quantitative reverse transcription PCR (qRT-PCR) in the early and late phases following the final dose.
Results:
The microdosing regimen did not impair sensorimotor gating or cognitive performance, indicating absence of psychotomimetic-like effects. Molecular analyses in the early phase revealed epigenetic remodelling in the mPFC, including increased histone H3 acetylation, change in bromodomain-containing protein 4 (BRD4) levels and modulation of histone deacetylases. These early molecular effects were associated with a transcriptionally permissive chromatin state and increased expression of genes related to plasticity. In the later phase, enhanced expression of the serotonin receptor 2A (5-HT2A) was observed, while some epigenetic modifications partially persisted over time.
Conclusions:
Repeated low-dose psilocybin promotes adaptive epigenetic remodelling in the mPFC, enhancing neuroplasticity without behavioural impairment and supporting its therapeutic potential.
Insights
Psilocybin microdosing enhances neuroplasticity via epigenetic changes in the rat medial prefrontal cortex (mPFC). This occurs without behavioral impairment, suggesting therapeutic potential for mood and anxiety disorders.
Area of Science:
- Neuroscience
- Epigenetics
- Pharmacology
Background:
- Psilocybin (PSI) microdosing is explored for affective and anxiety disorders.
- Molecular mechanisms, especially epigenetic regulation in the medial prefrontal cortex (mPFC), are poorly understood.
Purpose of the Study:
- Investigate if PSI microdosing causes adaptive epigenetic changes in the rat mPFC.
- Focus on chromatin accessibility, transcriptional regulators, and plasticity genes.
- Assess behavioral effects to ensure no dysfunction.
Main Methods:
- Rats received PSI or vehicle every other day for 21 days.
- Behavioral tests included prepulse inhibition (PPI) and novel object recognition (NOR).
- mPFC molecular analysis used Western blot and qRT-PCR at early and late phases.
Main Results:
- No impairment in sensorimotor gating or cognition was observed.
- Early phase: increased histone H3 acetylation, altered BRD4 levels, and modified histone deacetylases.
- Early phase: transcriptionally permissive chromatin and increased plasticity gene expression.
- Late phase: enhanced serotonin receptor 2A (5-HT2A) expression; some epigenetic changes persisted.
Conclusions:
- Repeated low-dose psilocybin promotes adaptive epigenetic remodeling in the mPFC.
- Enhances neuroplasticity without causing behavioral impairment.
- Supports psilocybin's therapeutic potential for mental health conditions.
